Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical preparation capable of improving animal immune function and preparation method thereof

A pharmaceutical preparation and animal immunization technology, which is applied in the field of pharmaceutical preparations with improved animal immune function and their preparation, can solve problems such as general growth promotion effect, and achieve improved liver function, good control effect, and improved animal intestinal flora. Effect

Inactive Publication Date: 2021-01-12
HENAN HEIMA ANIMAL PHARM CO LTD
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The object of the present invention is to provide a kind of pharmaceutical preparation and its preparation method that can improve animal immune function, to solve the existing pharmaceutical preparations that improve animal immune function proposed in the above-mentioned background technology when enhancing animal immune function to its growth promoting effect. The problem

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical preparation capable of improving animal immune function and preparation method thereof
  • Pharmaceutical preparation capable of improving animal immune function and preparation method thereof
  • Pharmaceutical preparation capable of improving animal immune function and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] see Figure 1-3 , an embodiment provided by the present invention: a pharmaceutical preparation for improving the immune function of animals, comprising the following components in mass percentage:

[0035] Complex bacteria series 26;

[0036] Boluohui extract 20%;

[0037] Pulsatilla 12%;

[0038] Pueraria 12%;

[0039] Scutellaria baicalensis 10%;

[0040] Andrographis paniculata 10%;

[0041] Qinpi 10%.

[0042] Further, the composite bacteria series can be composite probiotics, which include several bacillus and their metabolites and suitable carriers.

[0043] Further, the bacillus series can be Bacillus subtilis, Bacillus licheniformis, Bacillus natto.

[0044] Further, the live bacteria content of Bacillus subtilis is ≥2×10 10 CFU / g, 1×10 11 CFU / g, 2×10 11 CFU / g, the live bacteria content of Bacillus licheniformis is ≥2×10 10 CFU / g, 1×10 11 CFU / g, 2×10 11 CFU / g, the live bacteria content of Bacillus natto is ≥ 5×10 9 CFU / g, 1×10 10 CFU / g.

[0045]...

Embodiment 2

[0055] see Figure 1-3 , an embodiment provided by the present invention: a pharmaceutical preparation for improving the immune function of animals, comprising the following components in mass percentage:

[0056]Compound bacteria series 30%;

[0057] Boluohui extract 23%;

[0058] Pulsatilla 12%;

[0059] Pueraria 12%;

[0060] Scutellaria baicalensis 8%;

[0061] Andrographis paniculata 8%;

[0062] Qinpi 7%.

[0063] Further, the composite bacteria series can be composite probiotics, which include several bacillus and their metabolites and suitable carriers.

[0064] Further, the bacillus series can be Bacillus subtilis, Bacillus licheniformis, Bacillus natto.

[0065] Further, the live bacteria content of Bacillus subtilis is ≥2×10 10 CFU / g, 1×10 11 CFU / g, 2×10 11 CFU / g, the live bacteria content of Bacillus licheniformis is ≥2×10 10 CFU / g, 1×10 11 CFU / g, 2×10 11 CFU / g, the live bacteria content of Bacillus natto is ≥ 5×10 9 CFU / g, 1×10 10 CFU / g.

[0066] F...

Embodiment 3

[0076] see Figure 1-3 , an embodiment provided by the present invention: a pharmaceutical preparation for improving the immune function of animals, comprising the following components in mass percentage:

[0077] Compound bacteria series 22%;

[0078] Boluohui extract 18%;

[0079] Pulsatilla 15%;

[0080] Pueraria 15%;

[0081] Scutellaria baicalensis 10%;

[0082] Andrographis paniculata 12%;

[0083] Qin Pi 8%.

[0084] Further, the composite bacteria series can be composite probiotics, which include several bacillus and their metabolites and suitable carriers.

[0085] Further, the bacillus series can be Bacillus subtilis, Bacillus licheniformis, Bacillus natto.

[0086] Further, the live bacteria content of Bacillus subtilis is ≥2×10 10 CFU / g, 1×10 11 CFU / g, 2×10 11 CFU / g, the live bacteria content of Bacillus licheniformis is ≥2×10 10 CFU / g, 1×10 11 CFU / g, 2×10 11 CFU / g, the live bacteria content of Bacillus natto is ≥ 5×10 9 CFU / g, 1×10 10 CFU / g.

[008...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical preparation capable of improving an animal immune function and a preparation method thereof, relates to the technical field of pharmaceutical preparations, andaims to solve the problem that an existing pharmaceutical preparation capable of improving the animal immune function has a general growth promoting effect on an animal when the animal immune function is enhanced. A compound bacterium series can be compound probiotics, and internally comprises a plurality of bacillus, metabolites of the bacillus and a proper carrier; a bacillus series can be bacillus subtilis, bacillus licheniformis and bacillus natto; the content of viable bacteria of the bacillus subtilis is greater than or equal to 2 * 10 <10>CFU / g, 1 * 10 <11>CFU / g and 2 * 10 <11>CFU / g; the content of viable bacteria of the bacillus licheniformis is greater than or equal to 2 * 10 <10>CFU / g, 1 * 10 <11>CFU / g and 2 * 10 <11>CFU / g; the content of viable bacteria of the bacillus natto isgreater than or equal to 5 * 10 <9>CFU / g and 1 * 10 <10>CFU / g; and the total alkali of a macleaya cordata extract is greater than or equal to 60 percent.

Description

technical field [0001] The invention relates to the technical field of pharmaceutical preparations, in particular to a pharmaceutical preparation capable of improving animal immune function and a preparation method thereof. Background technique [0002] Animal pharmacy is a specialized specialty, which mainly studies the basic knowledge and skills of animal pharmacology, pharmacy, chemistry, and pharmacy, and conducts the production, inspection, analysis, marketing, and control of animal drugs. For example: processing and production of veterinary drugs, preparations and prescriptions, testing and analysis of specific components and contents of veterinary drugs, inspection and testing of veterinary drug quality, efficacy, and safety, sales and after-sales services of veterinary drugs, etc. [0003] However, the existing pharmaceutical preparations for improving the immune function of animals have a general problem of their growth-promoting effect when enhancing the immune fun...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/71A61K9/14A61P31/04A61P37/04A61P43/00A61K35/742
CPCA61K9/0056A61K9/14A61K35/742A61K36/19A61K36/488A61K36/539A61K36/63A61K36/66A61K36/71A61P31/04A61P37/04A61P43/00A61K2300/00
Inventor 孙美鹤保广春郭宇鹏
Owner HENAN HEIMA ANIMAL PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com